Quantitative evaluation of the role of Epstein-Barr virus immediate-early protein BZLF1 in B-cell transformation

Journal of General Virology

Volumn 90, Issue 10, 2009, Pages 2331-2341

  Katsumura, Koichi Ricardo ^a   Maruo, Seiji ^a   Wu, Yi ^a   Kanda, Teru ^a,b   Takada, Kenzo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN BZLF1; BZLF1 PROTEIN, HERPESVIRUS 4, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL GROWTH; CONTROLLED STUDY; EPISOME; EPSTEIN BARR VIRUS; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE NUMBER; HUMAN; HUMAN CELL; IN VITRO STUDY; KNOCKOUT GENE; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STUDY; SEQUENCE HOMOLOGY; STEADY STATE; VIRUS REPLICATION; WILD TYPE; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; PLASMID; TUMOR CELL LINE; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

B-LYMPHOCYTES; CELL LINE, TUMOR; GENE DELETION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCYTE ACTIVATION; PLASMIDS; TRANS-ACTIVATORS; VIRUS LATENCY;

EID: 70350503088     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.012831-0     Document Type: Article

References (62)

1. Adamson, A. L. & Kenney, S. (1999). The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J Virol 73, 6551-6558.
2. Beatty, P. R., Krams, S. M. & Martinez, O. M. (1997). Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J Immunol 158, 4045-4051.
3. Cayrol, C. & Flemington, E. K. (1996). The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J 15, 2748-2759.
4. Chang, Y. N., Dong, D. L., Hayward, G. S. & Hayward, S. D. (1990). The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. J Virol 64, 3358-3369.
5. Chang, Y., Lee, H. H., Chen, Y. T., Lu, J., Wu, S. Y., Chen, C. W., Takada, K. & Tsai, C. H. (2006). Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta. J Virol 80, 7748-7755.
6. Cohen, J. I., Wang, F., Mannick, J. & Kieff, E. (1989). Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci U S A 86, 9558-9562.
7. Countryman, J. & Miller, G. (1985). Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci U S A 82, 4085-4089.
8. Farrell, P. J., Rowe, D. T., Rooney, C. M. & Kouzarides, T. (1989). Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J 8, 127-132.
9. Feederle, R., Kost, M., Baumann, M., Janz, A., Drouet, E., Hammerschmidt, W. & Delecluse, H. J. (2000). The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19, 3080-3089.
10. Feederle, R., Neuhierl, B., Bannert, H., Geletneky, K., Shannon-Lowe, C. & Delecluse, H. J. (2007). Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. Int J Cancer 121, 588-594.
11. Feng, W. H., Kraus, R. J., Dickerson, S. J., Lim, H. J., Jones, R. J., Yu, X., Mertz, J. E. & Kenney, S. C. (2007). ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells. J Virol 81, 10113-10122.
12. Flemington, E. & Speck, S. H. (1990). Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c- fos. J Virol 64, 4549-4552.
13. Flemington, E. K., Borras, A. M., Lytle, J. P. & Speck, S. H. (1992). Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain. J Virol 66, 922-929.
14. Hammerschmidt, W. & Sugden, B. (1989). Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340, 393-397.
15. Hong, G. K., Gulley, M. L., Feng, W. H., Delecluse, H. J., Holley-Guthrie, E. & Kenney, S. C. (2005). Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model. J Virol 79, 13993-14003.
16. Hsu, D. H., de Waal Malefyt, R., Fiorentino, D. F., Dang, M. N., Vieira, P., de Vries, J., Spits, H., Mosmann, T. R. & Moore, K. W. (1990). Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250, 830-832.
17. Hsu, M., Wu, S. Y., Chang, S. S., Su, I. J., Tsai, C. H., Lai, S. J., Shiau, A. L., Takada, K. & Chang, Y. (2008). Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells. J Virol 82, 3679-3688.
18. Humme, S., Reisbach, G., Feederle, R., Delecluse, H. J., Bousset, K., Hammerschmidt, W. & Schepers, A. (2003). The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc Natl Acad Sci U S A 100, 10989-10994.
19. Imai, S., Nishikawa, J. & Takada, K. (1998). Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72, 4371-4378.
20. Isobe, Y., Sugimoto, K., Yang, L., Tamayose, K., Egashira, M., Kaneko, T., Takada, K. & Oshimi, K. (2004). Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells. Cancer Res 64, 2167-2174.
21. Iwakiri, D. & Takada, K. (2004). Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation. J Immunol 172, 1561-1566.
22. Jones, R. J., Dickerson, S., Bhende, P. M., Delecluse, H. J. & Kenney, S. C. (2007a). Epstein-Barr virus lytic infection induces retinoic acid-responsive genes through induction of a retinol-metabolizing enzyme, DHRS9. J Biol Chem 282, 8317-8324.
23. Jones, R. J., Seaman, W. T., Feng, W. H., Barlow, E., Dickerson, S., Delecluse, H. J. & Kenney, S. C. (2007b). Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease. Int J Cancer 121, 1274-1281.
24. Kanda, T., Kamiya, M., Maruo, S., Iwakiri, D. & Takada, K. (2007). Symmetrical localization of extrachromosomally replicating viral genomes on sister chromatids. J Cell Sci 120, 1529-1539.
25. Kaye, K. M., Izumi, K. M. & Kieff, E. (1993). Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A 90, 9150-9154.
26. Kelleher, C. A., Paterson, R. K., Dreyfus, D. H., Streib, J. E., Xu, J. W., Takase, K., Jones, J. F. & Gelfand, E. W. (1995). Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Virology 208, 685-695.
27. Kieff, E. & Rickinson, A. B. (2007). Epstein-Barr virus and its replication. In Fields Virology, 5th edn, pp. 2603-2654. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
28. Lieberman, P. M. & Berk, A. J. (1991). The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction. Genes Dev 5, 2441-2454.
29. Lieberman, P. M. & Berk, A. J. (1994). A mechanism for TAFs in transcriptional activation: activation domain enhancement of TFIID-TFIIA - promoter DNA complex formation. Genes Dev 8, 995-1006.
30. Mahot, S., Sergeant, A., Drouet, E. & Gruffat, H. (2003). A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene. J Gen Virol 84, 965-974.
31. Mannick, J. B., Cohen, J. I., Birkenbach, M., Marchini, A. & Kieff, E. (1991). The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J Virol 65, 6826-6837.
32. Maruo, S., Yang, L. & Takada, K. (2001). Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells. J Gen Virol 82, 2373-2383.
33. Maruo, S., Johannsen, E., Illanes, D., Cooper, A. & Kieff, E. (2003). Epstein-Barr virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth. J Virol 77, 10437-10447.
34. Maruo, S., Wu, Y., Ishikawa, S., Kanda, T., Iwakiri, D. & Takada, K. (2006). Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells. Proc Natl Acad Sci U S A 103, 19500-19505.
35. 2 and a mitotic block. J Virol 76, 10030-10037.
36. Mauser, A., Holley-Guthrie, E., Zanation, A., Yarborough, W., Kaufmann, W., Klingelhutz, A., Seaman, W. T. & Kenney, S. (2002b). The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. J Virol 76, 12543-12552.
37. Nanbo, A., Inoue, K., Adachi-Takasawa, K. & Takada, K. (2002). Epstein-Barr virus RNA confers resistance to interferon-α-induced apoptosis in Burkitt's lymphoma. EMBO J 21, 954-965.
38. Nanbo, A., Sugden, A. & Sugden, B. (2007). The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells. EMBO J 26, 4252-4262.
39. Pfüller, R. & Hammerschmidt, W. (1996). Plasmid-like replicative intermediates of the Epstein-Barr virus lytic origin of DNA replication. J Virol 70, 3423-3431.
40. Rickinson, A. B. & Kieff, E. (2007). Epstein-Barr virus. In Fields Virology, 5th edn, pp. 2655-2700. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
41. Rodriguez, A., Armstrong, M., Dwyer, D. & Flemington, E. (1999). Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta. J Virol 73, 9029-9038.
42. Rodriguez, A., Jung, E. J., Yin, Q., Cayrol, C. & Flemington, E. K. (2001). Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest. Virology 284, 159-169.
43. Savard, M., Bélanger, C., Tardif, M., Gourde, P., Flamand, L. & Gosselin, J. (2000). Infection of primary human monocytes by Epstein-Barr virus. J Virol 74, 2612-2619.
44. Scala, G., Quinto, I., Ruocco, M. R., Arcucci, A., Mallardo, M., Caretto, P., Forni, G. & Venuta, S. (1990). Expression of an exogenous interleukin 6 gene in human Epstein-Barr virus B cells confers growth advantage and in vivo tumorigenicity. J Exp Med 172, 61-68.
45. Shimizu, N., Tanabe-Tochikura, A., Kuroiwa, Y. & Takada, K. (1994). Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 68, 6069-6073.
46. Shimizu, N., Yoshiyama, H. & Takada, K. (1996). Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J Virol 70, 7260-7263.
47. Sinclair, A. J. (2003). bZIP proteins of human gammaherpesviruses. J Gen Virol 84, 1941-1949.
48. Stuart, A. D., Stewart, J. P., Arrand, J. R. & Mackett, M. (1995). The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes. Oncogene 11, 1711-1719.
49. Sugden, B., Phelps, M. & Domoradzki, J. (1979). Epstein-Barr virus DNA is amplified in transformed lymphocytes. J Virol 31, 590-595.
50. Takada, K., Shimizu, N., Sakuma, S. & Ono, Y. (1986). trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol 57, 1016-1022.
51. Takada, K., Horinouchi, K., Ono, Y., Aya, T., Osato, T., Takahashi, M. & Hayasaka, S. (1991). An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5, 147-156.
52. Tomkinson, B., Robertson, E. & Kieff, E. (1993). Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 67, 2014-2025.
53. Tosato, G., Tanner, J., Jones, K. D., Revel, M. & Pike, S. E. (1990). Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J Virol 64, 3033-3041.
54. Tsurumi, T., Fujita, M. & Kudoh, A. (2005). Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol 15, 3-15.
55. Wen, W., Iwakiri, D., Yamamoto, K., Maruo, S., Kanda, T. & Takada, K. (2007). Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. J Virol 81, 1037-1042.
56. 1 cell cycle arrest during the Epstein-Barr virus lytic cycle. J Virol 77, 1481-1500.
57. Wu, Y., Maruo, S., Yajima, M., Kanda, T. & Takada, K. (2007). Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation. J Virol 81, 11236-11245.
58. Yajima, M., Kanda, T. & Takada, K. (2005). Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation. J Virol 79, 4298-4307.
59. Yokoi, T., Miyawaki, T., Yachie, A., Kato, K., Kasahara, Y. & Taniguchi, N. (1990). Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor. Immunology 70, 100-105.
60. Yoshiyama, H., Imai, S., Shimizu, N. & Takada, K. (1997). Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol 71, 5688-5691.
61. Zerby, D., Chen, C. J., Poon, E., Lee, D., Shiekhattar, R. & Lieberman, P. M. (1999). The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus. Mol Cell Biol 19, 1617-1626.
62. Zhang, Q., Gutsch, D. & Kenney, S. (1994). Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol Cell Biol 14, 1929-1938.